Should we look for Strongyloides stercoralis in foreign-born HIV-infected persons?

Journal of Immigrant and Minority Health

Volumn 15, Issue 4, 2013, Pages 796-802

  Llenas García, Jara ^a   Fiorante, Silvana ^a,b   Salto, Efrén ^c   Maseda, Diego ^a   Rodríguez, Violeta ^a   Matarranz, Mariano ^a   Hernando, Asunción ^b   Rubio, Rafael ^a   Pulido, Federico ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^c Universidad Complutense   (Spain)

Author keywords

HIV; Hyperinfection syndrome; Immigrants; Screening; Strongyloides stercoralis

Indexed keywords

IMMUNOGLOBULIN G; IVERMECTIN;

ADULT; AFRICA SOUTH OF THE SAHARA; ANIMAL; CARIBBEAN; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; FEMALE; HUMAN; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; SOUTH AND CENTRAL AMERICA; SPAIN; STANDARDS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

ADULT; AFRICA SOUTH OF THE SAHARA; ANIMALS; CARIBBEAN REGION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IVERMECTIN; LATIN AMERICA; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MIDDLE AGED; SPAIN; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

MLCS; MLOWN;

EID: 84880149134     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-012-9756-6     Document Type: Article

References (39)

1. Instituto Nacional de Estadística. Avance del padrón municipal a 1 de enero de 2010. Población por lugar de nacimiento y sexo, 2010.
2. Centro Nacional de Epidemiología. Vigilancia epidemiológica del VIH en españa. Nuevos diagnósticos de VIH en españa. Periodo 2003-2009.: Sistemas de información sobre nuevos diagnósticos de VIH autonómicos, Actualización 30 de junio de 2010.
3. Siddiqui A, Genta R, Berk S. Strongyloidiasis. In: Guerrant R, Walker D, Weller P, editors. Tropical infectious diseases: principles, pathogens, & practice. Philadelphia: Elsevier; 2006. p. 1274-85.
4. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev. 2004;17:208-17.
5. Viney ME, Brown M, Omoding NE, Bailey JW, Gardner MP, Roberts E, Morgan D, Elliott AM, Whitworth JA. Why does HIV infection not lead to disseminated strongyloidiasis? J Infect Dis. 2004;190:2175-80.
6. Karp CL, Auwaerter PG. Coinfection with HIV and tropical infectious diseases II. Helminthic, fungal, bacterial, and viral pathogens. Clin Infect Dis. 2007;45:1214-20.
7. Taylor C, Subbarao V, Gayed S, Ustianowski A. Immune reconstitution syndrome to Strongyloides stercoralis infection. AIDS. 2007;21:649-50.
8. Kim A, Lupatkin H. Strongyloides stercoralis infection as a manifestation of immune restoration syndrome. Clin Infect Dis. 2004;39:439-40.
9. Lanzafame M, Faggian F, Lattuada E, Antolini D, Vento S. Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration. J Infect Dis. 2005;191:1027.
10. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis. 2001;33:1040-7.
11. Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg. 1995;53:248-50.
12. Keystone JS. Can one afford not to screen for parasites in high-risk immigrant populations? Clin Infect Dis. 2007;45:1316-8.
13. Loutfy M, Wilson M, Keystone J, Kain K. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002;66:749-52.
14. Speare R, Durrheim D. Strongyloides serology-useful for diagnosis and management of strongyloidiasis in rural indigenous populations, but important gaps in knowledge remain. Rural Remote Health. 2004;4:264.
15. Nuesch R, Zimmerli L, Stockli R, Gyr N, Christoph Hatz F. Imported strongyloidosis: a longitudinal analysis of 31 cases. J Travel Med. 2005;12:80-4.
16. Karunajeewa H, Kelly H, Leslie D, Leydon J, Saykao P, Biggs B. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis. J Travel Med. 2006;13:84-91.
17. AIDS study group (GESIDA) and National AIDS Plan Expert Committee: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. Enferm infecc microbiol clin. Spain, 2008, vol 26, pp 356-379.
18. Martin Sanchez AM, Hernandez Garcia A, Gonzalez Fernandez M, Afonso Rodriguez O, Hernandez Cabrera M, Perez Arellano JL. Parasitosis intestinales en poblacion inmigrante subsahariana asintomatica. Gran canaria 2000. Rev Clin Esp. 2004;204:14-7.
19. Assefa S, Erko B, Medhin G, Assefa Z, Shimelis T. Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count. BMC Infect Dis. 2009;9:155.
20. Feitosa G, Bandeira AC, Sampaio DP, Badaro R, Brites C. High prevalence of giardiasis and stronglyloidiasis among HIV-infected patients in Bahia, Brazil. Braz J Infect Dis. 2001;5:339-44.
21. Getaneh A, Medhin G, Shimelis T. Cryptosporidium and Strongyloides stercoralis infections among people with and without HIV infection and efficiency of diagnostic methods for Strongyloides in Yirgalem Hospital, southern Ethiopia. BMC Res Notes. 2010;3:90.
22. Hailemariam G, Kassu A, Abebe G, Abate E, Damte D, Mekonnen E, Ota F. Intestinal parasitic infections in HIV/AIDS and HIV seronegative individuals in a teaching hospital, Ethiopia. Jpn J Infect Dis. 2004;57:41-3.
23. Wiwanitkit V. Intestinal parasitic infections in Thai HIV-infected patients with different immunity status. BMC Gastroenterol. 2001;1:3.
24. Pinlaor S, Mootsikapun P, Pinlaor P, Pipitgool V, Tuangnadee R. Detection of opportunistic and non-opportunistic intestinal parasites and liver flukes in HIV-positive and HIV-negative subjects. Southeast Asian J Trop Med Public Health. 2005;36:841-5.
25. Kaminsky RG, Soto RJ, Campa A, Baum MK. Intestinal parasitic infections and eosinophilia in an human immunedeficiency virus positive population in Honduras. Mem Inst Oswaldo Cruz. 2004;99:773-8.
26. Walson JL, Stewart BT, Sangare L, Mbogo LW, Otieno PA, Piper BK, Richardson BA, John-Stewart G. Prevalence and correlates of helminth co-infection in kenyan HIV-1 infected adults. PLoS Negl Trop Dis. 2010;4:e644.
27. Bachur TP, Vale JM, Coelho IC, Queiroz TR, Chaves Cde S. Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy. Braz J Infect Dis. 2008;12:115-22.
28. Sarner L, Fakoya AO, Tawana C, Allen E, Copas AJ, Chiodini PL, Fenton KA. The utility of screening for parasitic infections in HIV-1-infected Africans with eosinophilia in London. Int J STD AIDS. 2007;18:626-9.
29. Hochberg NS, Moro RN, Sheth AN, Montgomery SP, Steurer F, McAuliffe IT, Wang YF, Armstrong W, Rivera HN, Lennox JL, Franco-Paredes C. High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States. PLoS Negl Trop Dis. 2011;5:e1034.
30. Martín-Rabadán P, Martínez-Ruiz R, Cuadros J, Cañavate C. El laboratorio de microbiología ante las enfermedades parasitarias importadas. Enferm Infecc Microbiol Clin. 2010;28:719-25.
31. Gonzaga HT, Ribeiro VS, Feliciano ND, Manhani MN, Silva DA, Ueta MT, Costa-Cruz JM. IgG avidity in differential serodiagnosis of human strongyloidiasis active infection. Immunol Lett. 2011;139:87-92.
32. Cagigi A, Nilsson A, Pensieroso S, Chiodi F. Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infect Dis. 2010;10:499-503.
33. Schaffel R, Nucci M, Carvalho E, Braga M, Almeida L, Portugal R, Pulcheri W. The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies. Am J Trop Med Hyg. 2001;65:346-50.
34. Santiago M, Leitão B. Prevention of Strongyloides hyperinfection syndrome: a rheumatological point of view. Eur J Intern Med. 2009;20:744-8.
35. Roxby AC, Gottlieb GS, Limaye AP. Strongyloidiasis in transplant patients. Clin Infect Dis. 2009;49:1411-23.
36. Kotton CN, Lattes R. Practice AIDCo: parasitic infections in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S234-51.
37. Muennig P, Pallin D, Challah C, Khan K. The cost-effectiveness of ivermectin vs. Albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States. Epidemiol Infect. 2004;132:1055-63.
38. Biggs BA, Caruana S, Mihrshahi S, Jolley D, Leydon J, Chea L, Nuon S. Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful? Am J Trop Med Hyg. 2009;80:788-91.
39. Kobayashi J, Sato Y, Toma H, Takara M, Shiroma Y. Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis. Diagn Microbiol Infect Dis. 1994;18:19-23.